ESMO BREAST 2021 - HER2-low breast cancer - what is it anyway?
Regarder maintenant
Q&A with Dr. Melanie Spears on the Characterisation of immune “hot” ER+ breast cancer
Regarder maintenant
ESMO 2021 - HER2-low breast cancer: evolution from primary breast cancer to relapse
Regarder maintenant
Primary outcome analysis of invasive disease-free survival for monarchE a Quebec perspective
Regarder maintenant
A Quebec clinical perspective of the randomized clinical trial SWOG S1007 (RxPonder)
Regarder maintenant
